0.4298
price up icon0.94%   0.0041
 
loading

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.75%
5.72
5.943 6.643 7.135 6.185
Operating Income/Loss
3.75%
-5.72
-5.943 -6.643 -7.135 -6.185
Income/Loss From Continuing Operations Before Tax
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Net Income/Loss
18.71%
-7.64
-6.436 -1.882 -10.59 -4.319
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
66.17%
15.53
9.3438 0.5322 3.7143 2.5432
Basic Earnings Per Share
28.99%
-0.49
-0.69 0.51 -2.85 -1.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.72
price down icon 0.23%
$83.24
price down icon 1.06%
$29.29
price down icon 0.78%
$98.88
price down icon 0.70%
$139.51
price down icon 0.64%
biotechnology ONC
$330.97
price up icon 0.33%
Kapitalisierung:     |  Volumen (24h):